Active	Status	Sponsor type	Region	Phase	Filter
3 Active 0 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Knoke, Leah
NCT05996835: Phase 2b Study to Investigate the Safety and Efficacy of TIN816 in Sepsis-associated Acute Kidney Injury (SA-AKI)	Recruiting	2	320	Europe, Canada, Japan, US, RoW	TIN816 70 mg lyophilisate powder, Placebo	Novartis Pharmaceuticals	Acute Kidney Injury Due to Sepsis	12/25	02/26
NCT02026388: Rare Kidney Stone Consortium Biobank	Recruiting	N/A	2000	US		Mayo Clinic	Primary Hyperoxaluria, Dent Disease, APRT Deficiency, Cystinuria	06/25	06/25
Garcia, Ofelia
NCT05996835: Phase 2b Study to Investigate the Safety and Efficacy of TIN816 in Sepsis-associated Acute Kidney Injury (SA-AKI)	Recruiting	2	320	Europe, Canada, Japan, US, RoW	TIN816 70 mg lyophilisate powder, Placebo	Novartis Pharmaceuticals	Acute Kidney Injury Due to Sepsis	12/25	02/26